APS Reading Tools
How to cite item
Anti-EGFR therapy can overcome acquired resistance to the third-generation ALK-tyrosine kinase inhibitor lorlatinib mediated by activation of EGFR
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{APS}{11331}, author = {Hu, C., Lu, C., Zheng, J., Kang, J., Huang, D., He, C., Liu, Y., Liu, Z., Wu, D., Dou, Y., Zhang, Y., Lin, C., Han, R., He, Y.}, title = {Anti-EGFR therapy can overcome acquired resistance to the third-generation ALK-tyrosine kinase inhibitor lorlatinib mediated by activation of EGFR}, journal = {Acta Pharmacologica Sinica}, volume = {46}, number = {8}, year = {2025}, url = {http://www.chinaphar.com/article/view/11331} }